New research underscores the need for public health interventions to improve the microbial and fiber content of diets in the US.
Quiz|Articles|January 24, 2024
Gastro Pop Quiz: Endoscopic Evaluation in Crohn Disease
Author(s)Kenneth Bender, PharmD, MA
A 10-second check of your GI IQ.
Advertisement
According to new American Gastroenterological Association guidelines on use of biomarkers to help manage Crohn disease endoscopic evaluation to rule out active inflammation after resolution of symptoms and normalization of biomarkers should occur:
Advertisement
Related to this article
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
2
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
5